Neurogene Inc. (NGNE)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
In fiscal 2025, Neurogene Inc. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $288.60M in total assets against $23.72M in total liabilities.
Key ratios (FY2025)
-34.1%
Return on equity
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $925.0K | $0 | — | — | — | — | $25.00M | — | — |
| Operating Income | -$103.33M | -$82.61M | -$55.58M | -$56.52M | -$60.70M | -$33.73M | -$70.96M | -$32.62M | -$51.12M | -$37.65M |
| Net Income | -$90.35M | -$75.14M | -$36.32M | -$55.19M | -$60.69M | -$33.28M | -$69.44M | -$31.59M | -$50.18M | -$37.00M |
| EPS (Diluted) | $-4.24 | $-4.28 | — | $-1.04 | $-1.10 | $-0.64 | — | — | — | — |
| Total Assets | $288.60M | $335.73M | $222.57M | $109.27M | $163.26M | $210.52M | $147.02M | $77.62M | $110.33M | $154.38M |
| Total Liabilities | $23.72M | $25.36M | $36.55M | $10.64M | $20.40M | $19.30M | $5.34M | $4.95M | $11.44M | $9.72M |
| Shareholders' Equity | $264.89M | $310.38M | $186.02M | -$145.74M | -$91.88M | $191.22M | $141.69M | $72.67M | $98.89M | $144.66M |
| Cash & Equivalents | $103.84M | $136.59M | $148.21M | $82.02M | $142.47M | $192.56M | $143.09M | $76.93M | $52.03M | $32.30M |
| Operating Cash Flow | -$77.17M | -$70.60M | -$51.42M | -$52.82M | -$47.56M | -$24.57M | -$15.39M | -$31.58M | -$44.72M | -$30.23M |
| Capital Expenditures | $1.18M | $808.0K | $321.0K | $2.23M | $3.26M | $2.22M | $879.0K | $49.0K | $494.0K | $713.0K |
| Shares Outstanding | 15.49M | 14.85M | 12.82M | 0 | 42.46M | 42.20M | 38.00M | 23.54M | 23.47M | 23.42M |